Cargando…
Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?
Metabolic changes during malignant transformation have been noted for many years in tumours. Otto Warburg first reported that cancer cells preferentially rely on glycolysis for energy production, even in the presence of oxygen, leading to the production of high levels of lactate. The crucial role of...
Autores principales: | Pértega-Gomes, Nelma, Baltazar, Fátima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227218/ https://www.ncbi.nlm.nih.gov/pubmed/25314297 http://dx.doi.org/10.3390/ijms151018333 |
Ejemplares similares
-
Clinical impact of the metabolic phenotype of prostate cancer: role of monocarboxylate transporters (MCTs)
por: Pértega-Gomes, Nelma, et al.
Publicado: (2013) -
A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2014) -
Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018) -
Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer
por: Valença, Isabel, et al.
Publicado: (2015) -
What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)